Neurosarcoidosis;Die neurosarkoidose

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 21, 1998, Pages 799-810

  Briner, V A ^a,b   Muller A ^a   Gebbers, J O ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b Kantonsspital Luzern Medizinische Klinik   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; METHOTREXATE; METHYLPREDNISOLONE;

ARTICLE; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; KVEIM TEST; LUNG BIOPSY; PROGNOSIS; SARCOIDOSIS;

ADULT; AGED; BRAIN; BRAIN DISEASES; CRANIAL NERVE DISEASES; CRANIAL NERVES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 0032560444     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990;69:261-76.
2. Scott TF. Neurosarcoidosis: Progress and clinical aspects. Neurology 1993;43:8-12.
3. Newmann LS, Rose CS, Maier LA. Sarkoidosis. N Engl J Med 1997;336:1224-34.
4. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. Am J Med 1977;63:86-108.
5. Mitchell DN, du Bois RM, Oldershaw PJ. Cardiac sarcoidosis. A potentially fatal condition that needs expert assessment. Br Med J 1997;314:320-1.
6. Winnacker JL, Becker KL, Katz S. Endocrine aspects of sarcoidosis. N Engl J Med 1968;278:427-34 und 483-92.
7. Marti HP, Laissue J, Mihatsch M, Cottier H, Truniger B. Renale Manifestationen der Sarkoidose. Schweiz Med Wochenschr 1988;118:413-21.
8. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-52.
9. Lebacq E, Verhaegen H, Desmet V. Renal involvement in sarcoidosis. Postgrad Med J 1970;46:526-9.
10. Takemura T, Matsui Y, Oritsu M, Akiyama O, Hiraga Y, et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies. Virchows Archiv A Pathol Anat 1991;418:361-8.
11. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neruol 1985; 42:909-17.
12. Delaney P. Neurologic manifestations in sarcoidosis. Review of the literature, with a report of 23 cases. Ann Intern Med 1977;336:336-45.
13. Nemni R, Galassi G, Cohen M, Hays AP, Gould R, et al. Symmetric sarcoid polyneuropathy: Analysis of a sural nerve biopsy. Neurology 1981;31:1217-23.
14. Zuniga G, Ropper AH, Frank J. Sarcoid peripheral neuropathy. Neurology 1991;41:1558-61.
15. Smith AS, Meisler DM, Weinstein MA, Tomsak RL, Hanson MR, et al. High-signal periventricular lesions in patients with Sarcoidosis: Neurosarcoidosis or Multiple sclerosis? Am J Roentgenol 1989;153:147-52.
16. Junger SS, Stern BJ, Levine SR, Sipos E, Marti-Masso JF. Intramedullary spinal sarcoidosis: Clinical and magnetic resonance imaging characteristics. Neurology 1993;43: 333-7.
17. Veres L, Utz JP, Houser OW. Sarcoidosis presenting as a central nervous system mass lesion. Chest 1997;111:518-21.
18. Manz HJ. Pathobiology of neurosarcoidosis and clinico-pathologic correlation. Can J Neurol Sci 1983;10:50-5.
19. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 1986;73:283-90.
20. Sharma OP. Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest 1997;112:220-8.
21. Luke RA, Stern BJ, Krumholz A, Johns CJ. Neurosarcoidosis: The long-term clinical course. Neurology 1987;37: 461-3.
22. Pentland B, Mitchell DJ, Cull RE, Ford MJ. Central nervous system sarcoidosis. Quart J Med 1985;220:457-65.
23. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Quart J Med, New Series 1983;208:525-33.
24. Chapelon C, Uzzan B, Piette JCh, Jacques C, Coche E, Godeau P. Sarcoidosis in internal medicine: A cooperative study of 554 cases. Ann Med Intern 1984;135:125-31.
25. Stern BJ, Griffin DE, Luke RA, Krumholz A, Johns CJ. Neurosarcoidosis: Cerebrospinal fluid lymphocyte subpopulations. Neurology 1987;37:878-81.
26. Scott TF, Seay AR, Goust JM. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis. Neurology 1989;39:1637-9.
27. Chan Seem CP, Norfolk G, Spokes EG. CSF angiotensin-converting enzyme in neurosarcoidosis. Lancet 1985;I: 456-7.
28. Oksanen V, Grönhagen-Riska C, Fyhrquist F, Somer H. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement. Acta Med Scand 1985;218: 123-7.
29. Allen RKA. A review of angiotensin converting enzyme in health and disease. Sarcoidosis 1991;8:95-100.
30. Case records of the Massachusetts General Hospital. Case 31-1995. N Engl J Med 1995;333:992-9.
31. Bell NH. Endocrine complications of sarcoidosis. Endocrin Metab North Am 1991;20:645-54.
32. 67Ga lung scans in assessing sarcoidosis. Experience in 14 research centers in seven different countries. Ann NY Acad Sci 1986;465:463-78.
33. Israel H, Gushue G, Park C. Assessment of galium-67 scanning in pulmonary and extrapulmonary sarcoidosis. Ann NY Acad Sci 1986;465:455-62.
34. Miller DH, Kendall BE, Barter S, Johnson G, MacManus DG, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988;38:378-83.
35. Hashmi M, Kyritsis AP. Diagnosis and treatment of intra-medullary spinal cord sarcoidosis. J Neurol 1998;245:178-85.
36. Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primariy angiitis of the central nervous system. J Rheumatol 1995;22:662-7.
37. Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arth Rheumat 1997;40:1189-201.
38. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapses to corticoid therapy. Chest 1997;111:623-31.
39. Warrens AN, Barnes PJ, Cole PJ, Mitchell DN. 'Pulsed' intravenous methyl-prednisolone therapy in refractory sarcoidosis. Thorax 1986;41:714-5.
40. Karnik AS. Nodular sarcoidosis simulating metastatic carcinoma. Arch Intern Med 1982;142:385-6.
41. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-51.
42. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumat 1995;34. 642-4.
43. Pacheo Y, Marechal C, Marechal F, Biot N, Perrin-Fayolle M. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 1985;2:107-13.
44. Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Chest 1988;94:202-3.
45. Kataria YP. Chlorambucil in sarcoidosis. Chest 1980;78: 36-42.
46. Kavanaugh AF, Andrew SL, Cooper B, Lawrence EC, Huston DP. Cyclosporine therapy of central nervous system sarcoidosis. Am J Med 1987;82:387-8.
47. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992;49:1065-72.
48. Feibelman R, Harman EM. Sarcoid Meningoencephalitis treated with high-dosage steroids and radiation [Letter]. Ann Intern Med 1985;102:136.
49. Garcia-Monco C, Berciano J. Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation [Letter]. J Neurol Neurosurg Psych 1988;51: 1594-6.
50. Popper HH, Klemen H, Hoefler G, Winter E. Presence of - mycobacterial DNA in sarcoidosis. Hum Pathol 1997; 28:796-800.
51. Mitchell DN. Mycobacteria and sarcoidosis. Lancet 1996;348:768-9.
52. Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997; 350:1655-61.
53. Krumholz A, Stern BJ, Stern EG. Clinical implications of seizures in neurosarcoidosis. Arch Neurol 1991;48:842-4.
54. Maisel JA, Lynam T. Unexpected sudden death in a young pregnant woman: unusual presentation of neurosarcoidosis. Ann Emerg Med 1996;28:94-7.
55. Thomas G, Murphey S, Staunton H, O'Neill S, Farrell MA, Brett FM. Pathogen-free granulomatous diseases of the central nervous system. Human Path 1998;29:110-5.